Publication | Closed Access

The potential cost-effectiveness of adding a human papillomavirus vaccine to the cervical cancer screening programme in South Africa

VaccinationCervical Cancer ManagementCervical Cancer ScreeningCervical CancerCervical HealthHuman Papillomavirus VaccinesCancer ScreeningPreventive MedicineSouth AfricaVaccine TrialVaccine EfficacyPublic HealthVaccine HesitancyMedicinePotential Cost-effectivenessEpidemiologyCervical Cancer Prevention